Application 208005
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FINGOLIMOD HYDROCHLORIDE | FINGOLIMOD HYDROCHLORIDE | CAPSULE;ORAL | EQ 0.5MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208005-001 | FINGOLIMOD HYDROCHLORIDE | FINGOLIMOD HYDROCHLORIDE | EQ 0.5MG BASE | CAPSULE / ORAL | 2021-01-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A208005-001 | FINGOLIMOD HYDROCHLORIDE | EQ 0.5MG BASE | CAPSULE / ORAL | 2021-01-19 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fingolimod | FINGOLIMOD HYDROCHLORIDE | Ascend Laboratories, LLC | 0f638feb-6986-41e4-8f9c-2e6b84a5bb44 | 2026-03-27 | Warnings, Adverse reactions | FINGOLIMOD HYDROCHLORIDE |
| FINGOLIMOD HYDROCHLORIDE | FINGOLIMOD HYDROCHLORIDE | Accord Healthcare Inc. | 65e59a51-c9c2-47b4-84fc-e0f8879eb26c | 2025-10-16 | Warnings, Adverse reactions | FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-4525 | Fingolimod | Fingolimod | Mylan Pharmaceuticals Inc. | ANDA | Current |